2,6-Dialkoxybenzamides, intermediates, pharamaceutical compositi

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26032647, 562474, A61K 3140, C07D20708

Patent

active

042320372

ABSTRACT:
A compound of the formula ##STR1## wherein R.sup.1 is an alkyl group with 1-3 carbon atoms, R.sup.2 and R.sup.3 are the same or different and each is hydrogen, chlorine or bromine; and pharmaceutically acceptable salts and optical isomers thereof; methods and intermediates for the preparation of the compounds; pharmaceutical preparations containing them and their medical use for the treatment of psychoses.

REFERENCES:
patent: 3342826 (1967-09-01), Miller et al.
patent: 3862139 (1975-01-01), Podesva et al.
patent: 4021567 (1977-05-01), Kaplan et al.
patent: 4029673 (1977-06-01), Bulteau et al.
Derwent Spec. No. 1588z; Werck & Co. (1/14/65).
Derwent Spec. No. 8188r (8/1/68).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,6-Dialkoxybenzamides, intermediates, pharamaceutical compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,6-Dialkoxybenzamides, intermediates, pharamaceutical compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,6-Dialkoxybenzamides, intermediates, pharamaceutical compositi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1645606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.